Here is the scientific program.
Keynote speakers:
Roger Kamm, Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, MIT
Alicia El Haj, Interdisciplinary Chair of Cell Engineering, Healthcare Technology Institute, University of Birmingham
Invited speakers (confirmed to date):
Davide Ambrosi, Politecnico di Torino, Italy
Anthony Callanan, University of Edinburgh, UK
Ruth Cameron, University of Cambridge, UK
Sonia Contera, University of Oxford, UK
Linda Cummings, New Jersey Institute of Technology, USA
Mohit Dalwadi, University of Oxford, UK
John Dunlop, University of Salzburg, Austria
John King, Nottingham, UK
Nati Korin, Technion, Israel
Catriona Lally, Trinity College Dublin, Ireland
Sandra Loerakker, TU Eindhoven, Netherlands
Ivan Martin, University of Basel, Switzerland
Scott McCue, Queensland University of Technology, Australia
Pierre-Alexis Mouthuy, University of Oxford, UK
Tom Mullin, University of Oxford, UK
Ramin Nasehi, Politecnico di Milano, Italy
Reuben O'Dea, University of Nottingham, UK
James Oliver, University of Oxford, UK
Ioannis Papantoniou, KU Leuven, Belgium
Ansgar Petersen, Julius Wolf Institute Berlin, Germany
Luigi Preziosi, Politecnico di Torino, Italy
Rebecca Shipley, University College London, UK
Barbara Wagner, Weierstrass Institute for Applied Analysis and Stochastics, Berlin
Cathy Ye, Oxford University, UK
Feihu Zhao, TU Eindhoven, Netherlands
Further Information
In vitro tissue engineering (TE) aims to create functional tissue and organ samples external to the body to replace damaged or diseased tissues and organs. By using cells (e.g. autologous or allogenic) in combination with natural or synthetic biomaterial scaffolds and biochemical factors, tissueengineered products have many advantages over traditional approaches such as donor tissue and organ transplantation that can elicit an adverse immune response. The development of the growing tissue construct, the combination of scaffold, cells, extracellular matrix (ECM) and biochemical factors, often occurs within a bioreactor that enables precise control of the bio-mechanochemical environment experienced by the cells within the growing construct.
This is particularly important in the development of mechanosensitive tissues, such as bone. Successfully engineering tissues in vitro has required the development of new smart biomaterials, new tissue growth strategies involving defined biological cues, and novel and bespoke bioreactor environments for growing tissue under physiological mechanical conditions. To date, only simple avascular tissues have been successfully generated to a standard where they can be used in a clinical setting, and research into methods for improving tissue viability is essential.
In TE systems, fluid and solid mechanics are used to provide mechanical load (e.g. via fluid shear, elastic deformation) to mechanosensitive tissues such as bone and vasculature, and a key challenge is to recreate the mechanical environment within the bioreactor system that is unique to the tissue under consideration. The fluid flows and solid deformations are intricate, requiring an understanding of novel fluid-structure interactions between the fluid flows, the cells and their ECM, and the (often deformable) biomaterial. Furthermore, successful tissue growth in bioreactor systems relies on appropriate solute delivery to and waste-product removal from the cells in the tissue construct. To promote transport (without recourse to agitation methods that can be damaging to cells in a tissue-engineering setting), fluid flows are exploited to enhance transport by advection.
In this colloquium, we will present state-of-the-art theoretical and experimental fluid and solid mechanics for TE, and explore the transformative potential of combined quantitative theoretical and experimental approaches to inform in vitro TE protocols. The theoretical models will be validated via detailed comparison of the theoretical model predictions with quantitative data obtained from state-of-the art biomechanics experiments. The hybrid approach of combining the resulting insights from the validated theoretical models with in vitro TE experiments can then be used to inform bioreactor and smart biomaterial design for TE strategies, with the aim of improving tissue viability.
Delegates are drawn from the theoretical and experimental fluid and solid mechanics communities. To ensure the focus remains applicable to the TE challenges, we have invited leading figures from the TE community, which will also facilitate new opportunities for interdisciplinary collaboration.